Biography
Tung-Kung Wu has completed his PhD degree in Biophysics from the Johns Hopkins University and Post-doctoral studies in Chemistry Department from Stanford University. He is appointed as a Professor in the Department of Biological Science and Technology at the National Chiao Tung University. His research interests include interdisciplinary fields of Bioorganic Chemistry, Chemical Biology, and Medicinal Chemistry. His current research interests mainly focus on the structure-reactivity relationships of glycoenzymes and mode of action of steryl glycosides as drug candidates.
Abstract
Steryl glycosides consist of a sterol/steroid aglycone and one or more sugar moieties linked through an ether or ester bond. Diverse biological activities including: anti-inflammatory, anti-fungal, anti-microbial, anti-parasitic and anti-tumor activities, and properties such as, cell membrane modification, regulation of host defenses against pathogens, lipid metabolism, and developmental events, have been attributed to this family of natural products. Development of structural diverse steryl glycosides may hold potential to identify candidates for new drug development and pharmaceutical applications. In this study, we functionally express different glycosyltransferases for in vitro synthesis of steryl glycosides with α- or β-configuration specificity. The synthesized steryl glycosides were investigated for their anticancer activity. Interestingly, several steryl glycosides show dose-dependent depression of cell viability and enhanced drug effectiveness on MCF-7 breast cancer cells. The structure-reactivity relationships of these glycosyltransferases on substrate‒donor specificities and mode of action of steryl glycosides on anticancer activity will be discussed.
Biography
Marra Vera Tarraga has completed her BSc in Chemistry and MSc in Organic Chemistry from Murcia University (Spain). She is currently a PhD student working on the synthesis of bioactive heterocyclic compounds.
Abstract
Owing to the wide variety of biological activities of heterocyclic compounds comprising a 2-pyrazoline moiety, the development of new preparative methods for this class of compounds has become a subject of great interest. We previously described the first synthesis of 3-aryl-5- dichloromethyl-2-pyrazolines 1 involving chloral and several chloral derivatives. Pyrazolines 1 were able to react with phenyl chloroformate to give the corresponding phenyl pyrazolinecarboxylates 2. These compounds were used as intermediates to obtain carbohydrazides 3, which were used in preparing carbohydrazones 4. A similar reaction sequence but using O-phenyl chlorothioformate instead of phenyl chloroformate provided good approaches to the respective intermediates 5, carbothiohydrazides 6 and carbothiohydrazones 7. The novel substances 3,4,6,7 were assayed to test their antitumoral properties against two leukemia cell lines, resulting IC50 values between: 4.38-20.01 μM (HL-60) and 2.19-17.05 μM (K562).